NYSE : DOCN
$17.36 (14.58%)
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-10 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-07-08 | Citigroup | Buy | Buy | Maintain |
| 2026-07-08 | UBS | Neutral | Neutral | Maintain |
| 2026-07-08 | Barclays | Overweight | Overweight | Maintain |
| 2026-06-11 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-05-12 | UBS | Neutral | Neutral | Maintain |
| 2026-05-07 | Citigroup | Buy | Buy | Maintain |
| 2026-05-07 | Goldman Sachs | Buy | Buy | Maintain |
| 2026-05-06 | Piper Sandler | Neutral | Neutral | Maintain |
| 2026-05-06 | UBS | Neutral | Neutral | Maintain |
| 2026-05-06 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-05-06 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-05-06 | Barclays | Overweight | Overweight | Maintain |
| 2026-05-01 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-04-28 | Citigroup | Buy | Buy | Maintain |
| 2026-04-28 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-04-21 | UBS | Neutral | Neutral | Maintain |
| 2026-04-21 | Barclays | Overweight | Overweight | Maintain |
| 2026-04-09 | B of A Securities | Buy | Buy | Maintain |
| 2026-04-07 | Piper Sandler | Neutral | Neutral | Maintain |
| 2026-03-26 | Citizens | Market Outperform | Market Outperform | Maintain |
| 2026-03-18 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-02-25 | Cantor Fitzgerald | Overweight | Overweight | Maintain |
| 2026-02-25 | Goldman Sachs | Buy | Buy | Maintain |
| 2026-02-25 | Barclays | Overweight | Overweight | Maintain |
| 2026-02-25 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-02-25 | Citizens | Market Outperform | Market Outperform | Maintain |
| 2026-02-25 | B of A Securities | Buy | Buy | Maintain |
| 2026-02-25 | UBS | Neutral | Neutral | Maintain |
| 2026-02-20 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-02-05 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
| 2026-01-27 | B of A Securities | Buy | Buy | Maintain |
| 2026-01-12 | Barclays | Overweight | Overweight | Maintain |
| 2026-01-05 | Piper Sandler | Neutral | Neutral | Maintain |